Click for best price
Fidaxomicin Market Size, Share 2022
This report contains market size and forecasts of Fidaxomicin in global, including the following market information:
The global Fidaxomicin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity:90% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fidaxomicin include Astellas, Merck, Optimer Pharmaceuticals, Rochem, Tecoland, BrightGene Bio-Medical Technology, Olon and Livzon Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Fidaxomicin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fidaxomicin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Tablets)
Global Fidaxomicin Market Segment Percentages, by Type, 2021 (%)
- Purity:90%
- Purity:95%
- Others
Global Fidaxomicin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Tablets)
Global Fidaxomicin Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Retail Pharmacies
Global Fidaxomicin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Tablets)
Global Fidaxomicin Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Fidaxomicin revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Fidaxomicin revenues share in global market, 2021 (%)
- Key companies Fidaxomicin sales in global market, 2017-2022 (Estimated), (K Tablets)
- Key companies Fidaxomicin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Astellas
- Merck
- Optimer Pharmaceuticals
- Rochem
- Tecoland
- BrightGene Bio-Medical Technology
- Olon
- Livzon Group
| Report Attributes |
Report Details |
| Report Title |
Fidaxomicin Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
78 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Fidaxomicin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fidaxomicin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fidaxomicin Overall Market Size
2.1 Global Fidaxomicin Market Size: 2021 VS 2028
2.2 Global Fidaxomicin Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Fidaxomicin Sales: 2017-2028
3 Company Landscape
3.1 Top Fidaxomicin Players in Global Market
3.2 Top Global Fidaxomicin Companies Ranked by Revenue
3.3 Global Fidaxomicin Revenue by Companies
3.4 Global Fidaxomicin Sales by Companies
3.5 Global Fidaxomicin Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Fidaxomicin Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Fidaxomicin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Fidaxomicin Players in Global Market
3.8.1 List of Global Tier 1 Fidaxomicin Companies
3.8.2 List of Global Tier 2 and Tier 3 Fidaxomicin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Fidaxomicin Market Size Markets, 2021 & 2028
4.1.2 Purity:90%
4.1.3 Purity:95%
4.1.4 Others
4.2 By Type - Global Fidaxomicin Revenue & Forecasts
4.2.1 By Type - Global Fidaxomicin Revenue, 2017-2022
4.2.2 By Type - Global Fidaxomicin Revenue, 2023-2028
4.2.3 By Type - Global Fidaxomicin Revenue Market Share, 2017-2028
4.3 By Type - Global Fidaxomicin Sales & Forecasts
4.3.1 By Type - Global Fidaxomicin Sales, 2017-2022
4.3.2 By Type - Global Fidaxomicin Sales, 2023-2028
4.3.3 By Type - Global Fidaxomicin Sales Market Share, 2017-2028
4.4 By Type - Global Fidaxomicin Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Fidaxomicin Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Retail Pharmacies
5.2 By Application - Global Fidaxomicin Revenue & Forecasts
5.2.1 By Application - Global Fidaxomicin Revenue, 2017-2022
5.2.2 By Application - Global Fidaxomicin Revenue, 2023-2028
5.2.3 By Application - Global Fidaxomicin Revenue Market Share, 2017-2028
5.3 By Application - Global Fidaxomicin Sales & Forecasts
5.3.1 By Application - Global Fidaxomicin Sales, 2017-2022
5.3.2 By Application - Global Fidaxomicin Sales, 2023-2028
5.3.3 By Application - Global Fidaxomicin Sales Market Share, 2017-2028
5.4 By Application - Global Fidaxomicin Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Fidaxomicin Market Size, 2021 & 2028
6.2 By Region - Global Fidaxomicin Revenue & Forecasts
6.2.1 By Region - Global Fidaxomicin Revenue, 2017-2022
6.2.2 By Region - Global Fidaxomicin Revenue, 2023-2028
6.2.3 By Region - Global Fidaxomicin Revenue Market Share, 2017-2028
6.3 By Region - Global Fidaxomicin Sales & Forecasts
6.3.1 By Region - Global Fidaxomicin Sales, 2017-2022
6.3.2 By Region - Global Fidaxomicin Sales, 2023-2028
6.3.3 By Region - Global Fidaxomicin Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Fidaxomicin Revenue, 2017-2028
6.4.2 By Country - North America Fidaxomicin Sales, 2017-2028
6.4.3 US Fidaxomicin Market Size, 2017-2028
6.4.4 Canada Fidaxomicin Market Size, 2017-2028
6.4.5 Mexico Fidaxomicin Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Fidaxomicin Revenue, 2017-2028
6.5.2 By Country - Europe Fidaxomicin Sales, 2017-2028
6.5.3 Germany Fidaxomicin Market Size, 2017-2028
6.5.4 France Fidaxomicin Market Size, 2017-2028
6.5.5 U.K. Fidaxomicin Market Size, 2017-2028
6.5.6 Italy Fidaxomicin Market Size, 2017-2028
6.5.7 Russia Fidaxomicin Market Size, 2017-2028
6.5.8 Nordic Countries Fidaxomicin Market Size, 2017-2028
6.5.9 Benelux Fidaxomicin Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Fidaxomicin Revenue, 2017-2028
6.6.2 By Region - Asia Fidaxomicin Sales, 2017-2028
6.6.3 China Fidaxomicin Market Size, 2017-2028
6.6.4 Japan Fidaxomicin Market Size, 2017-2028
6.6.5 South Korea Fidaxomicin Market Size, 2017-2028
6.6.6 Southeast Asia Fidaxomicin Market Size, 2017-2028
6.6.7 India Fidaxomicin Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Fidaxomicin Revenue, 2017-2028
6.7.2 By Country - South America Fidaxomicin Sales, 2017-2028
6.7.3 Brazil Fidaxomicin Market Size, 2017-2028
6.7.4 Argentina Fidaxomicin Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Fidaxomicin Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Fidaxomicin Sales, 2017-2028
6.8.3 Turkey Fidaxomicin Market Size, 2017-2028
6.8.4 Israel Fidaxomicin Market Size, 2017-2028
6.8.5 Saudi Arabia Fidaxomicin Market Size, 2017-2028
6.8.6 UAE Fidaxomicin Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Astellas
7.1.1 Astellas Corporate Summary
7.1.2 Astellas Business Overview
7.1.3 Astellas Fidaxomicin Major Product Offerings
7.1.4 Astellas Fidaxomicin Sales and Revenue in Global (2017-2022)
7.1.5 Astellas Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Fidaxomicin Major Product Offerings
7.2.4 Merck Fidaxomicin Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Optimer Pharmaceuticals
7.3.1 Optimer Pharmaceuticals Corporate Summary
7.3.2 Optimer Pharmaceuticals Business Overview
7.3.3 Optimer Pharmaceuticals Fidaxomicin Major Product Offerings
7.3.4 Optimer Pharmaceuticals Fidaxomicin Sales and Revenue in Global (2017-2022)
7.3.5 Optimer Pharmaceuticals Key News
7.4 Rochem
7.4.1 Rochem Corporate Summary
7.4.2 Rochem Business Overview
7.4.3 Rochem Fidaxomicin Major Product Offerings
7.4.4 Rochem Fidaxomicin Sales and Revenue in Global (2017-2022)
7.4.5 Rochem Key News
7.5 Tecoland
7.5.1 Tecoland Corporate Summary
7.5.2 Tecoland Business Overview
7.5.3 Tecoland Fidaxomicin Major Product Offerings
7.5.4 Tecoland Fidaxomicin Sales and Revenue in Global (2017-2022)
7.5.5 Tecoland Key News
7.6 BrightGene Bio-Medical Technology
7.6.1 BrightGene Bio-Medical Technology Corporate Summary
7.6.2 BrightGene Bio-Medical Technology Business Overview
7.6.3 BrightGene Bio-Medical Technology Fidaxomicin Major Product Offerings
7.6.4 BrightGene Bio-Medical Technology Fidaxomicin Sales and Revenue in Global (2017-2022)
7.6.5 BrightGene Bio-Medical Technology Key News
7.7 Olon
7.7.1 Olon Corporate Summary
7.7.2 Olon Business Overview
7.7.3 Olon Fidaxomicin Major Product Offerings
7.7.4 Olon Fidaxomicin Sales and Revenue in Global (2017-2022)
7.7.5 Olon Key News
7.8 Livzon Group
7.8.1 Livzon Group Corporate Summary
7.8.2 Livzon Group Business Overview
7.8.3 Livzon Group Fidaxomicin Major Product Offerings
7.8.4 Livzon Group Fidaxomicin Sales and Revenue in Global (2017-2022)
7.8.5 Livzon Group Key News
8 Global Fidaxomicin Production Capacity, Analysis
8.1 Global Fidaxomicin Production Capacity, 2017-2028
8.2 Fidaxomicin Production Capacity of Key Manufacturers in Global Market
8.3 Global Fidaxomicin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Fidaxomicin Supply Chain Analysis
10.1 Fidaxomicin Industry Value Chain
10.2 Fidaxomicin Upstream Market
10.3 Fidaxomicin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Fidaxomicin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Fidaxomicin in Global Market
Table 2. Top Fidaxomicin Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Fidaxomicin Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Fidaxomicin Revenue Share by Companies, 2017-2022
Table 5. Global Fidaxomicin Sales by Companies, (K Tablets), 2017-2022
Table 6. Global Fidaxomicin Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Fidaxomicin Price (2017-2022) & (USD/ Tablets)
Table 8. Global Manufacturers Fidaxomicin Product Type
Table 9. List of Global Tier 1 Fidaxomicin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fidaxomicin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Fidaxomicin Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Fidaxomicin Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Fidaxomicin Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Fidaxomicin Sales (K Tablets), 2017-2022
Table 15. By Type - Global Fidaxomicin Sales (K Tablets), 2023-2028
Table 16. By Application ? Global Fidaxomicin Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Fidaxomicin Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Fidaxomicin Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Fidaxomicin Sales (K Tablets), 2017-2022
Table 20. By Application - Global Fidaxomicin Sales (K Tablets), 2023-2028
Table 21. By Region ? Global Fidaxomicin Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Fidaxomicin Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Fidaxomicin Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Fidaxomicin Sales (K Tablets), 2017-2022
Table 25. By Region - Global Fidaxomicin Sales (K Tablets), 2023-2028
Table 26. By Country - North America Fidaxomicin Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Fidaxomicin Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Fidaxomicin Sales, (K Tablets), 2017-2022
Table 29. By Country - North America Fidaxomicin Sales, (K Tablets), 2023-2028
Table 30. By Country - Europe Fidaxomicin Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Fidaxomicin Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Fidaxomicin Sales, (K Tablets), 2017-2022
Table 33. By Country - Europe Fidaxomicin Sales, (K Tablets), 2023-2028
Table 34. By Region - Asia Fidaxomicin Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Fidaxomicin Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Fidaxomicin Sales, (K Tablets), 2017-2022
Table 37. By Region - Asia Fidaxomicin Sales, (K Tablets), 2023-2028
Table 38. By Country - South America Fidaxomicin Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Fidaxomicin Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Fidaxomicin Sales, (K Tablets), 2017-2022
Table 41. By Country - South America Fidaxomicin Sales, (K Tablets), 2023-2028
Table 42. By Country - Middle East & Africa Fidaxomicin Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Fidaxomicin Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Fidaxomicin Sales, (K Tablets), 2017-2022
Table 45. By Country - Middle East & Africa Fidaxomicin Sales, (K Tablets), 2023-2028
Table 46. Astellas Corporate Summary
Table 47. Astellas Fidaxomicin Product Offerings
Table 48. Astellas Fidaxomicin Sales (K Tablets), Revenue (US$, Mn) and Average Price (USD/ Tablets) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Fidaxomicin Product Offerings
Table 51. Merck Fidaxomicin Sales (K Tablets), Revenue (US$, Mn) and Average Price (USD/ Tablets) (2017-2022)
Table 52. Optimer Pharmaceuticals Corporate Summary
Table 53. Optimer Pharmaceuticals Fidaxomicin Product Offerings
Table 54. Optimer Pharmaceuticals Fidaxomicin Sales (K Tablets), Revenue (US$, Mn) and Average Price (USD/ Tablets) (2017-2022)
Table 55. Rochem Corporate Summary
Table 56. Rochem Fidaxomicin Product Offerings
Table 57. Rochem Fidaxomicin Sales (K Tablets), Revenue (US$, Mn) and Average Price (USD/ Tablets) (2017-2022)
Table 58. Tecoland Corporate Summary
Table 59. Tecoland Fidaxomicin Product Offerings
Table 60. Tecoland Fidaxomicin Sales (K Tablets), Revenue (US$, Mn) and Average Price (USD/ Tablets) (2017-2022)
Table 61. BrightGene Bio-Medical Technology Corporate Summary
Table 62. BrightGene Bio-Medical Technology Fidaxomicin Product Offerings
Table 63. BrightGene Bio-Medical Technology Fidaxomicin Sales (K Tablets), Revenue (US$, Mn) and Average Price (USD/ Tablets) (2017-2022)
Table 64. Olon Corporate Summary
Table 65. Olon Fidaxomicin Product Offerings
Table 66. Olon Fidaxomicin Sales (K Tablets), Revenue (US$, Mn) and Average Price (USD/ Tablets) (2017-2022)
Table 67. Livzon Group Corporate Summary
Table 68. Livzon Group Fidaxomicin Product Offerings
Table 69. Livzon Group Fidaxomicin Sales (K Tablets), Revenue (US$, Mn) and Average Price (USD/ Tablets) (2017-2022)
Table 70. Fidaxomicin Production Capacity (K Tablets) of Key Manufacturers in Global Market, 2020-2022 (K Tablets)
Table 71. Global Fidaxomicin Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Fidaxomicin Production by Region, 2017-2022 (K Tablets)
Table 73. Global Fidaxomicin Production by Region, 2023-2028 (K Tablets)
Table 74. Fidaxomicin Market Opportunities & Trends in Global Market
Table 75. Fidaxomicin Market Drivers in Global Market
Table 76. Fidaxomicin Market Restraints in Global Market
Table 77. Fidaxomicin Raw Materials
Table 78. Fidaxomicin Raw Materials Suppliers in Global Market
Table 79. Typical Fidaxomicin Downstream
Table 80. Fidaxomicin Downstream Clients in Global Market
Table 81. Fidaxomicin Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Fidaxomicin Segment by Type
Figure 2. Fidaxomicin Segment by Application
Figure 3. Global Fidaxomicin Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Fidaxomicin Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Fidaxomicin Revenue, 2017-2028 (US$, Mn)
Figure 7. Fidaxomicin Sales in Global Market: 2017-2028 (K Tablets)
Figure 8. The Top 3 and 5 Players Market Share by Fidaxomicin Revenue in 2021
Figure 9. By Type - Global Fidaxomicin Sales Market Share, 2017-2028
Figure 10. By Type - Global Fidaxomicin Revenue Market Share, 2017-2028
Figure 11. By Type - Global Fidaxomicin Price (USD/ Tablets), 2017-2028
Figure 12. By Application - Global Fidaxomicin Sales Market Share, 2017-2028
Figure 13. By Application - Global Fidaxomicin Revenue Market Share, 2017-2028
Figure 14. By Application - Global Fidaxomicin Price (USD/ Tablets), 2017-2028
Figure 15. By Region - Global Fidaxomicin Sales Market Share, 2017-2028
Figure 16. By Region - Global Fidaxomicin Revenue Market Share, 2017-2028
Figure 17. By Country - North America Fidaxomicin Revenue Market Share, 2017-2028
Figure 18. By Country - North America Fidaxomicin Sales Market Share, 2017-2028
Figure 19. US Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Fidaxomicin Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Fidaxomicin Sales Market Share, 2017-2028
Figure 24. Germany Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 25. France Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Fidaxomicin Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Fidaxomicin Sales Market Share, 2017-2028
Figure 33. China Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 37. India Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Fidaxomicin Revenue Market Share, 2017-2028
Figure 39. By Country - South America Fidaxomicin Sales Market Share, 2017-2028
Figure 40. Brazil Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Fidaxomicin Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Fidaxomicin Sales Market Share, 2017-2028
Figure 44. Turkey Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Fidaxomicin Revenue, (US$, Mn), 2017-2028
Figure 48. Global Fidaxomicin Production Capacity (K Tablets), 2017-2028
Figure 49. The Percentage of Production Fidaxomicin by Region, 2021 VS 2028
Figure 50. Fidaxomicin Industry Value Chain
Figure 51. Marketing Channels
